Knee Hyaluronic Acid Injections Market Forecast To Reach $4.35 Billion By 2030: Key Trends Explained
Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Knee Hyaluronic Acid Injections Market Value Analysis: What Growth Lies Ahead Over The Forecast Period?
The knee hyaluronic acid injections market has experienced robust expansion over recent years. It is projected to increase from $3.17 billion in 2025 to $3.37 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.4%. This historical growth can be linked to factors such as the increasing occurrence of osteoarthritis, a rising elderly demographic, wider embrace of viscosupplementation treatments, the proliferation of orthopedic services in hospitals, and the scarcity of past surgical options.
The knee hyaluronic acid injections market is projected to experience substantial expansion over the coming years. This market is set to reach $4.35 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.6%. This anticipated growth during the forecast period is primarily driven by advancements in hyaluronic acid formulation technologies, a rising demand for minimally invasive joint treatments, increased healthcare spending on orthopedic care, the expansion of outpatient and ambulatory surgical infrastructure, and a growing emphasis on regenerative and biological therapies. Key trends during this period include the increasing adoption of single-injection viscosupplementation for osteoarthritis, a growing preference for minimally invasive orthopedic treatments, the expanding geriatric population boosting demand for osteoarthritis solutions, the proliferation of outpatient orthopedic and ambulatory care facilities, and enhanced clinical research into the efficacy of hyaluronic acid molecular weight.
Get A Free Sample Report With In-Depth Market Insights:
Knee Hyaluronic Acid Injections Market Development Factors: What’s Supporting Demand?
The increasing occurrence of obesity is projected to boost the expansion of the knee hyaluronic acid injections market moving ahead. Obesity is defined as a medical state characterized by an excessive buildup of body fat, posing health dangers, and typically assessed via body mass index (BMI). The frequency of obesity is rising due to inactive lifestyles and decreased physical movement, which contribute to excess weight gain and related health issues. Knee hyaluronic acid injections aid in managing osteoarthritis symptoms in obese individuals by reinstating joint lubrication, diminishing inflammation, and enhancing mobility. For example, in May 2025, the Office for Health Improvement and Disparities, a UK-based government entity, reported that an estimated 64.5% of adults aged 18 and above in England were categorized as overweight or obese between 2023 and 2024. This marked a minor rise from the 64.0% observed in 2022–2023. Consequently, the growing incidence of obesity is fueling the demand in the knee hyaluronic acid injections market.
Knee Hyaluronic Acid Injections Market Segment Landscape: Which Areas Lead Development?
The knee hyaluronic acid injections market covered in this report is segmented –
1) By Product Type: Single Injection, Three Injection, Five Injection
2) By Indication: Knee Osteoarthritis, Ligament Injury, Post Arthroscopy, Other Indications
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
4) By Application: Osteoarthritis, Rheumatoid Arthritis, Other Applications
5) By End User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Single Injection: Cross-Linked Hyaluronic Acid Injections, Non-Cross-Linked Hyaluronic Acid Injections, High Molecular Weight Hyaluronic Acid Injections, Low Molecular Weight Hyaluronic Acid Injections, Visco supplementation Hyaluronic Acid Injections
2) By Three Injection: Cross-Linked Hyaluronic Acid Injections, Non-Cross-Linked Hyaluronic Acid Injections, High Molecular Weight Hyaluronic Acid Injections, Low Molecular Weight Hyaluronic Acid Injections, Visco supplementation Hyaluronic Acid Injections
3) By Five Injection: Cross-Linked Hyaluronic Acid Injections, Non-Cross-Linked Hyaluronic Acid Injections, High Molecular Weight Hyaluronic Acid Injections, Low Molecular Weight Hyaluronic Acid Injections, Visco supplementation Hyaluronic Acid Injections
Knee Hyaluronic Acid Injections Market Transformation Trends: What Innovations Are Driving Change?
Major companies operating in the knee hyaluronic acid injections market are prioritizing the development of advanced therapies, such as single-injection HA knee treatments. These innovations aim to restore synovial fluid viscosity, reduce pain, and improve joint function through a single intra-articular administration, eliminating the need for multiple injections. A single-injection HA knee treatment describes a medical procedure where a solitary dose of hyaluronic acid (HA) is injected into the knee joint to alleviate pain and enhance mobility, primarily in patients with osteoarthritis. For instance, in July 2024, LG Chem, a South Korea-based life sciences and pharmaceutical company, introduced Synovian (branded in China as Hyruan ONE). This product is a cross-linked hyaluronic acid injection for knee osteoarthritis in the Chinese market that offers therapeutic benefits comparable to multi-injection regimens, simplifies treatment to just one visit, and demonstrated safety and efficacy in Phase-3 clinical trials among Chinese patients. Synovian’s convenience as a single-dose treatment, its cross-linked HA formulation ensuring longer intra-articular residence, and its inclusion on China’s National Reimbursement Drug List collectively promote broader adoption and improved patient compliance, although the extent of physician training and insurance uptake varies across different regions.
Knee Hyaluronic Acid Injections Market Leading Players And Competitive Positioning
Major companies operating in the knee hyaluronic acid injections market are Johnson & Johnson, Sanofi S. A., Teva Pharmaceutical Industries Ltd., Smith & Nephew plc, Chugai Pharmaceutical Co. Ltd., Zimmer Biomet Holdings Inc., Bioventus Inc., Fidia Farmaceutici S. p. A., Ferring Pharmaceuticals A/S, IBSA Institut Biochimique SA, Anika Therapeutics Inc., Lifecore Biomedical LLC, TRB Chemedica International S. A., Seikagaku Corporation, Hangzhou Singclean Medical Products Co. Ltd., Virchow Biotech Private Limited, OrthogenRx Inc., Shanghai Haohai Biological Technology Co. Ltd., Allergan plc, Shandong Freda Biochem Co. Ltd.
View The Full Knee Hyaluronic Acid Injections Market Report:
Knee Hyaluronic Acid Injections Market Regional Split: Which Areas Are Fueling Growth?
North America was the largest region in the knee hyaluronic acid injections market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the knee hyaluronic acid injections market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
